Document Type : Original Research


1 Oral and Maxillofacial Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Oral and Maxillofacial Pathology, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran

3 Department of Radiotherapy Oncology and Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran


Background & Objective: The present study investigated the relationship between invasive front (IF) of tumors and clinicopathological parameters including stage, grade, nodal involvement, lymphocytic host response (LHR), recurrence, overall survival (OS), and disease-free survival (DFS).
Methods: A total of 87 oral squamous cell carcinoma (OSCC) biopsies were evaluated. Clinical stage, grading, nodal involvement, time of recurrence, OS, and DFS were assessed. The number of tumor budding cells in the IF was measured by two pathologists with an optic microscope. IF was graded to low risk (<5) and high risk (>5), according to the counting of tumor budding as a single cancer cell or cluster cells. Also, LHR was reported in the IF as mild, moderate, and severe.
Results: IF was reported in 43.7% of patients as a low-risk group and 49.4% as a high-risk group. LHR was also mild in 31%, moderate in 25.3%, and severe in 43.7% of the patients. Most of the patients were in stage IV (31%) and grade 1 (60.9%). The high risk IF group had a significant statistical relationship with stage (P=0.001), grade (P=0.039), five years OS (P=0.03), five years DSF (P=0.01), and lymph node involvement (P=0.007). The relation between LHR and stage of disease was significant (P=0.034).
Conclusion: Considering the important role of histopathological reports in the treatment plan of patients and the relationship between IF and clinical parameters, IF evaluation in routine histopathological examinations, especially in the early stages of OSCC, seems to be necessary.


Main Subjects

  1. Geum D-H, Roh Y-C, Yoon S-Y, Kim H-G, Lee J-H, Song J-M, et al. The impact factors on 5-year survival rate in patients operated with oral cancer. J Korean Assoc Oral Maxillofac Surg. 2013;39(5):207-16. [DOI:10.5125/jkaoms.2013.39.5.207] [PMID] [PMCID]
  2. Liu S-A, Wong Y-K, Lin J-C, Poon C-K, Tung K-C, Tsai W-C. Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse. Otolaryngol Head Neck Surg. 2007;136(1):112-8. [DOI:10.1016/j.otohns.2006.07.002] [PMID]
  3. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral oncol. 2009;45(4-5):309-16. [DOI:10.1016/j.oraloncology.2008.06.002] [PMID]
  4. Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue-clinicopathologic features affecting outcome. Cancer. 2012;118(1):101-11. [DOI:10.1002/cncr.26229] [PMID]
  5. Ho CM, Lam KH, Wei WI, Lau SK, Lam LK. Occult lymph node metastasis in small oral tongue cancers. Head neck. 1992;14(5):359-63. [DOI:10.1002/hed.2880140504] [PMID]
  6. Warrier S, Bhuvanalakshmi G, Arfuso F, Rajan G, Millward M, Dharmarajan A. Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition. Cancer Gene Ther. 2014;21(9):381-8. [DOI:10.1038/cgt.2014.42] [PMID]
  7. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005;5(9):744-9. [DOI:10.1038/nrc1694] [PMID]
  8. Brabletz T. To differentiate or not-routes towards metastasis. Nat Rev Cancer. 2012;12(6):425-36. [DOI:10.1038/nrc3265] [PMID]
  9. Christofori G. New signals from the invasive front. Nature. 2006;441(7092):444-50. [DOI:10.1038/nature04872] [PMID]
  10. Masuda R, Kijima H, Imamura N, Aruga N, Nakamura Y, Masuda D, et al. Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients. Mol Med Rep. 2012;6(5):937-43. [DOI:10.3892/mmr.2012.1048] [PMID] [PMCID]
  11. Koelzer VH, Langer R, Zlobec I, Lugli A. Tumor budding in upper gastrointestinal carcinomas. Front Oncol. 2014;4:216. [DOI:10.3389/fonc.2014.00216] [PMID] [PMCID]
  12. Lugli A, Karamitopoulou E, Zlobec I. Tumour budding: a promising parameter in colorectal cancer. Br J Cancer. 2012;106(11):1713-7. [DOI:10.1038/bjc.2012.127] [PMID] [PMCID]
  13. Brown M, Sillah K, Griffiths EA, Swindell R, West CM, Page RD, et al. Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro‐oesophageal junction cancers. Histopathology. 2010;56(7):893-9. [DOI:10.1111/j.1365-2559.2010.03559.x] [PMID]
  14. Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29(2):167-78. [DOI:10.1097/01.pas.0000149687.90710.21] [PMID]
  15. Imai T. The growth of human carcinoma: a morphological analysis. Fukuoka Igaku Zasshi. 1954;45(30).
  16. Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R. Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol. 2012;25(10):1315-25. [DOI:10.1038/modpathol.2012.94] [PMID]
  17. Bryne M, Koppang HS, Lilleng R, Kjærheim Å. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992;166(4):375-81. [DOI:10.1002/path.1711660409] [PMID]
  18. Kawashiri S, Tanaka A, Noguchi N, Hase T, Nakaya H, Ohara T, et al. Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity. Head Neck. 2009;31(10):1346-53. [DOI:10.1002/hed.21097] [PMID]
  19. Bankfalvi A, Piffko J. Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med. 2000;29(7):291-8. [DOI:10.1034/j.1600-0714.2000.290701.x] [PMID]
  20. Mohtasham N, Babakoohi S, Shiva A, Shadman A, Kamyab-Hesari K, Shakeri M-T, et al. Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity. Pathol Res Pract. 2013;209(2):110-4. [DOI:10.1016/j.prp.2012.11.002] [PMID]
  21. Niwa Y, Yamada S, Koike M, Kanda M, Fujii T, Nakayama G, et al. Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2014;110(6):764-9. [DOI:10.1002/jso.23694] [PMID]
  22. Almangush A, Salo T, Hagström J, Leivo I. Tumour budding in head and neck squamous cell carcinoma-a systematic review. Histopathology. 2014;65(5):587-94. [DOI:10.1111/his.12471] [PMID]
  23. Ueno H, Price AB, Wilkinson KH, Jass JR, Mochizuki H, Talbot IC. A new prognostic staging system for rectal cancer. Ann Surg. 2004;240(5):832. [DOI:10.1097/01.sla.0000143243.81014.f2] [PMID] [PMCID]
  24. Wang C, Huang H, Huang Z, Wang A, Chen X, Huang L, et al. Tumor budding correlates with poor prognosis and epithelial‐mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med. 2011;40(7):545-51. [DOI:10.1111/j.1600-0714.2011.01041.x] [PMID] [PMCID]
  25. Rahrotaban S, Mahdavi N, Abdollahi A, Yazdani F, Kaghazloo A, Derakhshan S. Carcinoma-associated Fibroblasts are a Common Finding in the Microenvironment of HPV-positive Oropharyngeal Squamous Cell Carcinoma. Appl Immunohistochem Mol Morphol. 2019;27(9):683-8. [DOI:10.1097/PAI.0000000000000687] [PMID]
  26. Xie N, Wang C, Liu X, Li R, Hou J, Chen X, et al. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early‐stage tongue squamous cell carcinoma. J Oral Pathol Med. 2015;44(4):266-72. [DOI:10.1111/jop.12242] [PMID]
  27. Almangush A, Bello IO, Keski-Säntti H, Mäkinen LK, Kauppila JH, Pukkila M, et al. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early‐stage oral tongue cancer. Head.Neck. 2014;36(6):811-8. [DOI:10.1002/hed.23380] [PMID] [PMCID]
  28. Hart IR, Goode NT, Wilson RE. Molecular aspects of the metastatic cascade. Biochim Biophys Acta. 1989;989(1):65-84. [DOI:10.1016/0304-419X(89)90035-8]
  29. Mohajertehran F, Ayatollahi H, Jafarian AH, Khazaeni K, Soukhtanloo M, Shakeri M-T, et al. Overexpression of lactate dehydrogenase in the saliva and tissues of patients with head and neck squamous cell carcinoma. Rep Biochem Mol Biol. 2019;7(2):142.
  30. Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor budding: the name is EMT. Partial EMT. J Clin Med. 2016;5(5):51. [DOI:10.3390/jcm5050051] [PMID] [PMCID]
  31. Kellermann M, Sobral L, Silva Sd, Zecchin K, Graner E, Lopes M, et al. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology. 2007;51(6):849-53. [DOI:10.1111/j.1365-2559.2007.02873.x] [PMID]
  32. Keski-Säntti H, Atula T, Tikka J, Hollmén J, Mäkitie AA, Leivo I. Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol. 2007;43(10):1007-13. [DOI:10.1016/j.oraloncology.2006.11.015] [PMID]
  33. Yamakawa N, Kirita T, Umeda M, Yanamoto S, Ota Y, Otsuru M, et al. Tumor budding and adjacent tissue at the invasive front correlate with delayed neck metastasis in clinical early‐stage tongue squamous cell carcinoma. J Surg Oncol. 2019;119(3):370-8. [DOI:10.1002/jso.25334] [PMID] [PMCID]
  34. Chaudhari RB. Cellular and molecular aspects at invasive tumor front in oral squamous cell carcinoma (part-I). SRM Journal of Research in Dental Sciences. 2016;7(3):166-72. [DOI:10.4103/0976-433X.188805]
  35. Almangush A, Coletta R, Bello I, Bitu C, Keski-Säntti H, Mäkinen L, et al. A simple novel prognostic model for early stage oral tongue cancer. I Int J Oral Maxillofac Surg. 2015;44(2):143-50. [DOI:10.1016/j.ijom.2014.10.004] [PMID]
  36. Li Y, Bai S, Carroll W, Dayan D, Dort JC, Heller K, et al. Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head Neck Pathol. 2013;7(3):211-23. [DOI:10.1007/s12105-012-0412-1] [PMID] [PMCID]
  37. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74. [DOI:10.1016/j.cell.2011.02.013] [PMID]
  38. Shahabinejad M, Asadi Z, Mohajertehran F. LAMP3 (CD208) Expression in Squamous Cell Carcinoma and Epithelial Dysplasia of the Oral Cavity and Clinicopathological Characteristics of Unfavorable Prognosis. Rep Biochem Molecul Biol. 2021 Jan;9(4):373. [DOI:10.52547/rbmb.9.4.373]
  39. Shahabinejad M, Zare R, Amouzad Mahdiraji A. Cytokeratins (CK7 and CK20) Genes Expression Association with Clinicopathological Indices in Oral Squamous Cell Carcinoma and Dysplastic Oral Epithelium. Reports of Biochemistry and Molecular Biology. 2021,126-34.